Rainer Walter

This inventor holds 21 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Kg, Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2000-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rainer Walter. Retrieved from https://idiyas.com/inventor/rainer-walter-qz088acm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 3)

% Patents Active = 90.5

CIPO Patents = 2

EPO Patents = 13 (Patent Applications = 13)

Average Co-Inventor Count = 7.3

ph-index = 6

Forward Citations = 134(Granted Patents)

Location History:

Biberach an der Riss, DE (2012)
Biberach, DE (2000 - 2014)

Company Filing History:

10 out of 1,562

Boehringer Ingelheim International Gmbh

patents

7 out of 149

Boehringer Ingelheim Pharma Kg

patents

4 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

Years Active: 2000-2014

Loading Chart...

Areas of Expertise:

Bradykinin B1-antagonists

Pharmaceutical Compositions

Indol-containing Beta-agonists

Kinase Inhibitors

Inflammatory Diseases

Receptor Tyrosine Kinases

Substituted Indolinones

Substituted Indolines

Lck Inhibitors

Immunologic Diseases

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8916589 - Bradykinin B1-antagonists (2014-12-23),

2. 8865702 - B1-antagonists (2014-10-21),

3. 8450306 - Bradykinin B1-receptor antagonists (2013-05-28),

4. 8394805 - Compounds (2013-03-12),

5. 8372838 - Compounds as bradykinin B1 antagonists (2013-02-12),

6. 8252785 - Aryl sulfonamides as bradykinin-B1-receptor antagonists (2012-08-28),

7. 8173699 - Compounds for the treatment of inflammatory diseases (2012-05-08),

8. 7989474 - Use of Lck inhibitors for treatment of immunologic diseases (2011-08-02),

9. 7858618 - Compounds (2010-12-28),

10. 7754756 - Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions (2010-07-13),

11. 7723381 - Compounds for the treatment of inflammatory diseases (2010-05-25),

12. 7166615 - Substituted indolinones, preparation thereof and their use as pharmaceutical compositions (2007-01-23),

13. 7160901 - Substituted indolinones, preparation thereof and their use as pharmaceutical compositions (2007-01-09),

14. 6855710 - Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs (2005-02-15),

15. 6794395 - Substituted indolinones, their manufacture and their use as medicaments (2004-09-21),

Title: Unveiling the Legacy of Rainer Walter: A Visionary Inventor

Introduction:

Rainer Walter, a dedicated inventor hailing from Biberach, DE, has made significant contributions to the field of pharmaceutical innovation with a total of 21 patents to his name. His passion for pushing the boundaries of science and his unwavering commitment to excellence have solidified his place as a visionary in the realm of invention.

Latest Patents:

Among his latest patents are groundbreaking inventions in the area of Bradykinin B1-antagonists. These compounds, including those of formula I, have shown valuable properties for treating diseases and symptoms caused, in part, by the stimulation of bradykinin-B1 receptors. The pharmaceutical compositions containing these compounds have opened new avenues for therapeutic interventions, marking Rainer Walter's innovative prowess.

Career Highlights:

Throughout his illustrious career, Rainer Walter has made notable contributions while working with prestigious companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma KG. His expertise and groundbreaking inventions have not only propelled the success of these organizations but have also left an indelible mark on the pharmaceutical industry.

Collaborations:

Collaboration plays a pivotal role in the realm of innovation, and Rainer Walter has had the privilege of working alongside esteemed colleagues such as Armin Heckel and Ingo Konetzki. Together, they have combined their expertise to drive forward cutting-edge research and development initiatives, shaping the future of pharmaceutical advancements.

Conclusion:

In conclusion, Rainer Walter's impact as a visionary inventor resonates far and wide, inspiring generations to push the boundaries of innovation. His relentless pursuit of excellence, coupled with his disruptive inventions in the pharmaceutical domain, cements his legacy as a trailblazer in the world of inventions. The mark he has left on the industry serves as a testament to the transformative power of innovation and the unwavering dedication of passionate inventors like Rainer Walter.

Profile summary based on public USPTO records.